OOIR: Observatory of International Research

Papers

(The H4-Index of Diabetes-Metabolism Research and Reviews is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
	439
Issue Information	305
Vision Loss as a Rising Global Health Challenge: Comprehensive Analysis of High Fasting Plasma Glucose Burden and Projections to 2035	192
Efficacy and safety of fixed‐ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta‐analysis of randomised controlled trials	181
Issue Information	169
The role of long non‐coding RNAs in the development of diabetic kidney disease and the involved clinical application	121
Early Postpartum Metabolic Heterogeneity Among Women Who Progressed to Type 2 Diabetes After Gestational Diabetes: A Prospective Cohort	120
Longitudinal cardiovascular health measured by life's essential 8 metrics with incident diabetes: A 13‐year prospective cohort study	111
Plasma ANGPTL7 Links Insulin Resistance to Heart Failure: Unveiling a Novel Fibro‐Metabolic Axis in Type 2 Diabetes	94
Effects of treatment with Glucagon‐like peptide‐1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta‐analysis	89
The circadian syndrome is a predictor for cognition impairment in middle‐aged adults: Comparison with the metabolic syndrome	77
Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking	73
Guidelines on the diagnosis and treatment of active Charcot neuro‐osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)	65
Central and Peripheral Sensitivity to Thyroid Hormones Correlate to Metabolically Obesity Phenotypes in Chinese Euthyroid Adults: A Cross‐Sectional Study	62
	61
Stuttering in adolescence and the risk for dysglycemia in early adulthood	60
The relationship between neonatal hypoglycaemia and cord blood C‐peptide levels in neonates of birthing individuals with type 1 diabetes	60
Predictors of change in hypoglycemia unawareness among patients with type 1 diabetes	58
Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes	57
Assessment of the spectrum of depression and bipolarity in patients with type 1 diabetes	55
Determinants of Prediabetes in Adolescents: Evidence From Indonesia	54
Development of a Chinese‐Specific Clinical Model to Predict Maturity‐Onset Diabetes of the Young	47
Classification of foot ulcers in people with diabetes: A systematic review	47
Issue Information	44
Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials	44

Withdrawal: Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquill	43
Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China	41
	40
Cover Image	40
Sex differences in the relationship between platelet count and type 2 diabetes risk in community‐dwelling adults: Longitudinal findings over 14 years	40
Cost‐Effectiveness of Artificial Intelligence Assisted Screening for Diabetic Retinopathy: A Markov Model	39
A multidisciplinary team reduces in‐hospital clinical complications and mortality in patients with diabetic foot ulcers	39
Fibre‐Enriched High‐Carbohydrate (FEHC) Diet Modulates Inflammation Without Affecting Bone Health in Older Women With Obesity: A Randomised Clinical Trial	38
Pep19: A Novel Approach for Reducing Visceral Fat and Improving Sleep Quality in Obese Adults—Results From an Early‐Stage Clinical Trial	38
Reduced early response to SARS‐CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow‐up study: The CoVaDiab study I	37
Risk of New‐Onset Ischaemic and Haemorrhagic Stroke in Patients With Type 2 Diabetes With Chronic Kidney Disease on SGLT‐2 Inhibitor Users: A Population‐Based Cohort Study	36
Association of thyroid stimulating hormone and time in range with risk of diabetic retinopathy in euthyroid type 2 diabetes	36